Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients?

Keyphrases

• Diagnostic Performance 100%
• Negative Predictive Value 100%
• Nodal Staging 100%
• Breast Cancer Patients 100%
• Axillary Ultrasound 100%
• Breast Cancer Subtypes 100%
• Human Epidermal Growth Factor Receptor 2 (HER2) 75%
• Triple-negative Tumor 75%
• HER2+ Tumors 75%
• Sensitivity Specificity 50%
• Axillary Surgery 50%
• HER2+ 50%
• ER + 50%
• Tumor 25%
• Positive Predictive Value 25%
• No Significant Difference 25%
• Performance Parameters 25%
• Prediction Accuracy 25%
• Cancer Cases 25%
• Chi-square Test 25%
• Imaging Findings 25%
• Axillary Lymph Node Metastasis 25%
• Primary Invasive Breast Cancer 25%
• Triple Negative Subtype 25%
• Bilateral Breast Cancer 25%
• Value Sensitivity 25%
• Histopathological Features 25%

INIS

• patients 100%
• cancer 100%
• diagnosis 100%
• breasts 100%
• tumors 87%
• values 62%
• specificity 25%
• sensitivity 25%
• surgery 25%
• accuracy 25%
• hospitals 12%
• populations 12%
• lymph nodes 12%
• metastases 12%
• gold 12%

Medicine and Dentistry

• Neoplasm 100%
• Breast Cancer 100%
• Diagnostic Performance 100%
• Axillary Surgery 28%
• Prevalence 14%
• Histopathology 14%
• Lymph Node Metastasis 14%
• Sensitivity and Specificity 14%
• Axillary Lymph Node 14%
• Malignant Neoplasm 14%
• Chi Square Test 14%